Literature DB >> 94337

Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia.

L S Weiner, J T Howell, M P Langford, G J Stanton, S Baron, R M Goldblum, R A Lord, A S Goldman.   

Abstract

The effects of specific antibodies in chronic echovirus type 5 (echo 5) encephalitis were investigated in a patient with x-linked hypogammaglobulinemia. Virus was detected in cerebrospinal fluid (CSF) and blood despite treatment with commercial human gammaglobulin that contained low titers of antibodies to echo 5 (0.6 x 10(4) units per injection). Virus disappeared from blood and CSF when plasma containing high concentrations of antibodies (total dose, 1--4 x 10(4) units/kg) was administered intravenously. Maximal inhibition of virus was achieved in culture and in the patient's CSF when the titer of antibody to echo 5 in CSF was greater than or equal to 16 units/ml. Although the patient died, hyperimmune plasma improved the neurologic status and eliminated detectable virus from the blood and CSF.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94337     DOI: 10.1093/infdis/140.6.858

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Failure of intraventricular gammaglobulin and alpha interferon for persistent encephalitis in congenital hypogammaglobulinaemia.

Authors:  D M Roberton; I Jack; W Joshi; F Law; C S Hosking
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

2.  Successful treatment of echovirus meningoencephalitis in sex-linked agammaglobulinaemia by intrathecal and intravenous injection of high titre gammaglobulin.

Authors:  H Kondoh; K Kobayashi; Y Sugio; T Hayashi
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

3.  Postinfection therapy of arbovirus infections in mice.

Authors:  I P Singh; D H Coppenhaver; M Sarzotti; P Sriyuktasuth; J Poast; H B Levy; S Baron
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  CD40 ligand deficiency: neurologic sequelae with radiographic correlation.

Authors:  Shrinivas Bishu; Deepak Madhavan; Phillip Perez; Lucy Civitello; Shuying Liu; Margaret Fessler; Steven M Holland; Ashish Jain; Maryland Pao
Journal:  Pediatr Neurol       Date:  2009-12       Impact factor: 3.372

5.  Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection.

Authors:  M P Langford; A L Villarreal; G J Stanton
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis.

Authors:  M P Langford; M Yin-Murphy; Y M Ho; J C Barber; S Baron; G J Stanton
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 7.  Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.

Authors:  T Chonmaitree; C D Baldwin; H L Lucia
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 8.  Mechanisms and consequences of virus persistence in the human nervous system.

Authors:  V ter Meulen; M J Carter; H Wege; R Watanabe
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.